Mr. John H. Van Drie Van Drie Research LLC, USA

John H. Van Drie is President of Van Drie Research LLC, a consulting group serving the pharma/biotech industry. As a molecular modeller, he has contributed to three successful drug discovery efforts: ritonavir (HIV protease), linezolid (antibiotic), and telaprevir (HCV protease). He is best known as a pioneer in virtual screening,... read morein his role as the author of ALADDIN, the first software for performing pharmacophore-based virtual screening, and in his role as a founding member of BioCAD, the startup that produced the drug discovery software Catalyst. Prior to founding Van Drie Research, he worked at Novartis, Vertex and Pharmacia. While at Pharmacia, he developed the pharmacophore discovery methods called DANTE. He did his graduate work in theoretical chemistry at Caltech.